American Research & Management Company’s Cantel Medical Corporation CMD Stock Holding History

American Research & Management Company’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-80	Closed	-$3K	–	369
2020 Q1	$3K	Sell	80 -150	-65%	-$8.53K	﹤0.01%	301
2019 Q4	$16K	Hold	230	–	–	﹤0.01%	256
2019 Q3	$17K	Hold	230	–	–	0.01%	254
2019 Q2	$19K	Hold	230	–	–	0.01%	263
2019 Q1	$15K	Hold	230	–	–	﹤0.01%	306
2018 Q4	$17K	Hold	230	–	–	0.01%	245
2018 Q3	$21K	Hold	230	–	–	0.01%	243
2018 Q2	$23K	Hold	230	–	–	0.01%	219
2018 Q1	$26K	Hold	230	–	–	0.01%	227
2017 Q4	$24K	Hold	230	–	–	0.01%	247
2017 Q3	$22K	Hold	230	–	–	0.01%	230
2017 Q2	$18K	Hold	230	–	–	0.01%	229
2017 Q1	$18K	Sell	230 -150	-39%	-$11.9K	0.01%	222
2016 Q4	$30K	Hold	380	–	–	0.01%	208
2016 Q3	$30K	Hold	380	–	–	0.01%	212
2016 Q2	$26K	Hold	380	–	–	0.01%	208
2016 Q1	$27K	Hold	380	–	–	0.01%	210
2015 Q4	$24K	Hold	380	–	–	0.01%	218
2015 Q3	$22K	Buy	+380	New	+$20.1K	0.01%	229

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

American Research & Management Company's CMD Position: Q2 2020 in Review

American Research & Management Company sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 80 shares — an estimated $3K sold.

American Research & Management Company first reported a position in CMD in Q3 2015 and held it in 19 quarters. The position peaked at $30K in Q4 2016. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

American Research & Management Company reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
American Research & Management Company sold 80 Cantel Medical Corporation shares in Q2 2020, an estimated $3K.
American Research & Management Company first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 19 quarters.
American Research & Management Company's Cantel Medical Corporation position peaked at $30K in Q4 2016.
210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on American Research & Management Company's 13F filing for Q2 2020, filed 28 Jul 2020.